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Abstract
Although  obesity  screening  and  treatment  are  recom-
mended by the US Preventive Services Task Force, 1 in 5 
women are obese when they conceive. Women are at risk 
for  complications  of  untreated  obesity  particularly  dur-
ing the reproductive years and may benefit from targeted 
screening. Risks of obesity and potential benefits of inter-
vention in this population are well characterized. Rates of 
adverse pregnancy outcomes including gestational diabe-
tes, preeclampsia, cesarean delivery, and stillbirth increase 
as maternal body mass index increases. Offspring risks 
include  higher  rates  of  congenital  anomalies,  abnormal 
intrauterine growth, and childhood obesity. Observational 
data suggest that weight loss may reduce risks of obesity-
related pregnancy complications. Although obesity screen-
ing has not been studied in women of reproductive age, the 
effect of obesity and the potential for significant maternal 
and fetal benefits make screening of women during the 
childbearing years an essential part of the effort to reduce 
the impact of the obesity epidemic.
Introduction
In 2009, 26% of US adult women reported a body mass 
index  (BMI)  in  the  obese  range  (≥30  kg/m2)  (1).  With 
rates  of  both  adult  and  adolescent  obesity  increasing, 
the prevalence of obesity among women of childbearing 
age (aged 15-44 y) can also be expected to increase. The 
US Preventive Services Task Force (2) and the National 
Heart, Lung, and Blood Institute (NHLBI) (3) recommend 
screening  all  adults  for  obesity  in  clinical  settings,  but 
neither specifically mentions screening for women during 
their reproductive years. Although the Centers for Disease 
Control and Prevention’s Select Panel on Preconception 
Care released recommendations in 2006 to improve the 
preconception care of women, which included addressing 
prepregnancy  obesity,  obesity  remains  an  undertreated 
chronic  disease  that  affects  at  least  1  in  5  pregnancies 
(4).  One  factor  contributing  to  the  gap  between  recom-
mendation and practice may be that for the 20% of women 
of childbearing age who are uninsured, preventive care 
services are often provided episodically in settings such as 
federally funded family planning programs rather than in 
traditional primary care settings.
The effect of untreated obesity among women of child-
bearing age includes adverse reproductive outcomes as 
well as adverse outcomes for these women’s offspring. 
Although  women  who  are  obese  may  be  at  increased 
risk for unplanned pregnancy and contraceptive failure 
(5),  infertility  rates  are  higher  among  obese  women 
than among normal-weight women (6). Once a woman 
is pregnant, both maternal and fetal risks are increased 
by high maternal BMI. Pregnancy-associated morbidity 
and mortality are higher in obese women than in nor-
mal-weight women (7). The offspring of obese women 
face  an  increased  risk  of  obesity  and  other  chronic 
metabolic diseases (8). Women of childbearing age are 
therefore a uniquely at-risk population who may ben-
efit from targeted screening.
Our objective was to develop recommendations for screen-
ing in women of childbearing age by focusing on the effica-
cy, benefits, and potential harms of screening in this popu-
lation. This article is part of a series of articles focused on 
screening women of reproductive age for chronic health 
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conditions, particularly women seeking care at clinics that 
receive Title X Family Planning funding.
We  systematically  reviewed  the  literature  on  obesity 
screening in women of reproductive age. We searched the 
MEDLINE database for articles published from January 1, 
1998, to July 1, 2010. We used the search terms “obesity” 
or “BMI” and “screen” or “assessment” limited to humans 
aged 19 to 64 years to identify potentially relevant articles. 
Using these parameters, we were unable to identify any 
studies that focused on the feasibility, acceptability, risks, 
benefits, or costs of obesity screening in women of child-
bearing age. We therefore chose to frame our discussion 
of  screening  by  summarizing  the  current  evidence  sur-
rounding the risks of obesity before and during pregnancy, 
reviewing potential risks and benefits of obesity treatment 
as part of preconception care, highlighting gaps in current 
screening practices, and proposing recommendations for 
screening opportunities in the population of women who 
may become pregnant.
Risks Associated With Obesity in Women of 
Childbearing Age
Although unplanned pregnancy is of concern in a popula-
tion at high risk for complications during pregnancy, obese 
women are less likely to use contraception than normal-
weight women (9). Furthermore, the counseling of obese 
women regarding contraceptive options is more complex 
than  for  women  of  normal  weight.  Although  contracep-
tive efficacy is generally high, there may be higher rates 
of failure of combined hormonal methods in obese women 
(10), and both intrauterine contraception placement and 
surgical sterilization are more technically challenging and 
more likely to result in complications (11) in women with 
a high BMI than in women of normal weight. Although 
the absolute risk of venous thromboembolism is small in 
obese women who use combined hormonal contraception, 
the risk is elevated relative to women who are not using 
combined contraception, and further study is needed to 
determine whether risks are higher in obese women than 
in normal-weight women (5).
The  risks  of  adverse  pregnancy  outcomes  increase  as 
maternal BMI increases beyond the normal range (BMI 
≥25  kg/m2).  Achieving  pregnancy  can  be  more  difficult 
for obese women because they are less likely to ovulate 
regularly, have decreased fecundity, and have increased 
risk  of  miscarriage  (6).  Gestational  diabetes  affects  as 
many  as  20%  of  pregnancies  in  women  who  are  obese, 
a  4-fold  increase  compared  with  normal-weight  women 
(12). Hypertension in pregnancy is more frequent in obese 
women,  and  they  have  a  2-  to  3-fold  increased  odds  of 
preeclampsia (12). The risk of preterm delivery in obese 
women  is  also  elevated,  likely  in  part  because  of  their 
increased risk of preeclampsia (12).
High maternal BMI is associated with intrapartum com-
plications. Induction of labor is more common in women 
with high BMI than in normal-weight women (12). Rates 
of both primary and repeat cesarean delivery increase with 
increasing maternal BMI, with trial of labor after cesarean 
less likely to be successful than in normal-weight women 
(12,13).  The  peripartum  complications  faced  by  obese 
women include a greater likelihood of infection, need for 
blood transfusion, and venous thromboembolism, particu-
larly with cesarean delivery (14). Prepregnancy obesity is 
also associated with a 3-fold increase in maternal death 
and near-miss morbidity (7).
In addition to the maternal consequences of obesity, there 
are significant implications of excess maternal weight to 
offspring. The risk of fetal anomalies including cleft pal-
ate, neural tube defects, and congenital heart disease is 
increased (15), and detection of anomalies is made more 
difficult because of the technical challenges of ultrasound 
in obese women. The risk of stillbirth among obese women 
is approximately double that among normal-weight women 
(16). Obese women are more likely to give birth to infants 
who are large for gestational age or macrosomic (14); these 
infants are at higher risk than their normal birth weight 
counterparts for long-term cardiometabolic complications, 
including obesity (8). Even normal birth weight offspring 
of obese mothers are more likely to be obese than offspring 
of normal-weight mothers (8), further fueling the obesity 
epidemic.
Preconception Interventions
The NHLBI has recommended treating all obese patients 
who  are  receptive  to  intervention,  while  acknowledging 
that a limitation of all therapies, including lifestyle inter-
vention, medical therapy, and surgical therapy, is a low 
rate  of  long-term  weight  maintenance  (3).  Nonetheless, 
randomized controlled trials of multiple weight-loss strate-
gies have demonstrated short-term efficacy. None of these 
trials has specifically focused on the treatment of obesity 
during  a  woman’s  reproductive  life,  particularly  before VOLUME 8: NO. 6
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conception.  Observational  data  suggest  that  interpreg-
nancy weight loss is associated with a decreased risk of 
preeclampsia, large-for-gestational-age birth weight, and 
cesarean delivery (17), compared with the previous preg-
nancy. Few studies have examined the effect of lifestyle 
interventions  or  medical  therapy  before  conception  on 
pregnancy outcomes. Several case series have attempted 
to  examine  the  effect  of  bariatric  surgery  by  compar-
ing outcomes in women who have had pregnancies both 
pre-  and  postoperatively,  or  by  choosing  normal-weight 
controls. There may be a decrease in infertility and spon-
taneous abortion in women who have undergone bariatric 
surgery  (5).  Consistent  findings  include  lower  rates  of 
gestational diabetes and hypertensive complications (18) 
after surgical intervention, without increases in fetal or 
maternal morbidity. One study of children of mothers who 
had  undergone  bariatric  surgery  found  that,  compared 
with children born before their mothers had bariatric sur-
gery, fewer children born after their mothers had bariatric 
surgery showed abnormalities in anthropometry and hor-
monal markers of cardiometabolic risk (19). While these 
data suggest that aggressive treatment of obesity may be 
warranted,  prospective  study  is  needed  to  quantify  the 
risks and benefits of both medical and surgical manage-
ment before pregnancy.
Obesity Screening
The rate of obesity screening in clinical practice is low. 
Obesity is underdiagnosed in primary care settings (20); 
consistently  fewer  than  half  of  obese  patients  have  a 
documented  obesity  diagnosis.  Similarly,  a  minority  of 
obese people report receiving weight-loss advice from their 
health care provider (21). Although some clinicians have 
argued  that  screening  is  unnecessary  because  patients 
have an adequate perception of body weight, mispercep-
tion of weight status is in fact widespread, with 1 study 
reporting that only 14% of obese women recruited from 
urban health centers in Atlanta correctly identified their 
weight status (22).
Theoretical risks of obesity screening include stigmatiza-
tion or psychological effects associated with the diagnosis 
of obesity; however, we were unable to identify literature 
substantiating  these  risks.  In  fact,  data  suggest  that 
awareness of weight status is beneficial. The 2003-2008 
National Health and Nutrition Examination Survey found 
that 98% of the women who correctly perceived themselves 
as overweight desired to weigh less and 72% were actively 
attempting  to  lose  weight,  compared  with  only  37%  of 
women  who  did  not  perceive  themselves  as  overweight 
(23).  Moreover,  overweight  and  obese  women  who  had 
received a diagnosis of overweight or obesity from their 
health care provider were twice as likely to endorse weight 
control  behaviors  (ie,  diet,  exercise)  as  women  who  did 
not have a formal diagnosis (23). The potential benefits 
of obesity screening as a part of preconception counseling 
remain unexplored.
Recommendations for Screening
Screening for obesity in women of reproductive age remains 
understudied as a population-level intervention. There are 
data, however, that support the basic tenets of screening 
for obesity in women during childbearing years. Obesity 
is a disease with measurable public health impact during 
the reproductive years, not just later in life. Screening for 
obesity by calculating BMI is a reproducible, simple, and 
inexpensive  technique  that  reliably  estimates  adiposity 
without the time and expense of less practical methods 
such as measurement of total body water (8). Although 
there are theoretical risks, including misdiagnosis, stigma 
associated with diagnosis, and extra cost associated with 
treatment, these risks have not been demonstrated in cur-
rent literature.
Finally, the potential benefits of screening include appro-
priate treatment with resultant weight loss, which may 
improve outcomes for women and their children. In par-
ticular, weight loss before pregnancy may have immedi-
ate  benefits  including  reduced  maternal  morbidity  and 
decreased risk of long-term cardiometabolic consequences 
for  children,  even  if  weight  loss  is  not  sustained  over 
time. At a minimum, identification of obesity before con-
ception allows for appropriate preconception counseling. 
Current  recommendations  from  the  American  Congress 
of Obstetricians and Gynecologists include discussion of 
specific maternal and fetal risks of prepregnancy obesity, 
counseling regarding the benefits of weight reduction, and 
management to identify early or minimize possible compli-
cations of obesity (24).
We are unaware of prior reviews of obesity screening that 
have focused on women of reproductive age. Although we 
were  not  able  to  identify  sufficient  literature  regarding 
obesity  screening  to  perform  a  meta-analysis,  evidence 
regarding the risks of untreated obesity in women of repro-
ductive age is substantial. The limited data on pregnancy VOLUME 8: NO. 6
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outcomes following the surgical treatment of obesity are 
promising and suggest there may be benefit to identifying 
and  treating  obesity  in  women  who  are  planning  preg-
nancy.
The American Congress of Obstetricians and Gynecologists 
is the only national body that has issued specific guidelines 
for screening women of reproductive age for obesity, with 
the recommendation that BMI be calculated for all women 
(24).  Despite  these  recommendations,  current  screening 
rates are low (20). Recognizing that many young women 
access the health care system sporadically and that nearly 
50% of pregnancies are unplanned, we believe that screen-
ing should be performed in settings beyond primary care 
clinics, including community health centers, college health 
service centers, and family planning clinics. We suggest 
that  women  of  childbearing  age  presenting  for  care  in 
these settings should be told their BMI after a measured 
weight and height are obtained.
The potential benefits of screening all women of childbear-
ing age include identification of women at high risk and 
referral to appropriate treatment before pregnancy. The 
American Dietetic Association and the American Society 
for  Nutrition  have  issued  a  joint  statement  supporting 
counseling all overweight and obese women of reproduc-
tive age on dietary modification and physical activity (25). 
Further data are needed to understand the effect that los-
ing a small amount of weight has on pregnancy outcomes. 
A  potential  harm  is  stigma,  although  this  risk  has  not 
been studied, and additional costs may be incurred with 
increased diagnosis of obesity. In resource-poor settings, 
follow-up care may be inadequate to ensure appropriate 
treatment  of  women  identified  in  broad  screening  pro-
grams. Although we acknowledge these potential pitfalls 
of widespread screening, we argue that simply identifying 
obesity may itself be an intervention because women who 
accurately perceive that they are overweight may be more 
likely to change their diet or demonstrate healthy weight-
related  behaviors  than  women  who  misperceive  their 
weight status (23).
Conclusions
Although obesity screening has not been studied specifi-
cally in women of reproductive age, there are compelling 
reasons to prioritize screening in this population. Women 
of childbearing age who are obese are at increased risk of 
infertility, miscarriage, and other adverse pregnancy out-
comes. Mounting evidence supports the intergenerational 
transmission of obesity as a result of an abnormal intra-
uterine  environment.  Although  randomized  controlled 
trials of intensive treatment of obesity before pregnancy 
have not yet been performed, observational data suggest 
the  possibility  that  weight  reduction  may  ameliorate 
these risks. Furthermore, clinicians who identify women 
as obese may be more likely to provide appropriate care 
and screening to identify and reduce risks for secondary 
complications  of  obesity.  Screening  of  reproductive-aged 
women is an essential part of broadening efforts to reduce 
the effect of the obesity epidemic in this country.
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